- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT03416907
Informed Consent Formats by Information Preference and Priority
Přehled studie
Postavení
Podmínky
Detailní popis
Typ studie
Zápis (Aktuální)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, Spojené státy, 15213
- Carnegie Mellon University
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- 18 Years Old or Older
- Read and agreed to informed consent
- Indicated desire to participate
- Diagnosed with asthma
- US resident
Exclusion Criteria:
- Participants from whom we receive multiple responses will be dropped from analysis (but will be compensated for participation)
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Základní věda
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
---|---|
Aktivní komparátor: Original
Participants will review the full-length, original consent form for the clinical trial.
|
Participants will review the full-length, original consent form for the clinical trial.
|
Experimentální: Shortened
Participants will review a shortened consent form for the clinical trial, which includes only material indicated as important by 2/3 of participants from a previous study.
|
Participants will review a shortened consent form for the clinical trial, which includes only material indicated as important by 2/3 of participants from a previous study.
|
Experimentální: Reordered
Participants will review a reordered, shortened consent form.
This form is based on the shortened consent form, but the sections are reordered based on a previous study, such that sentences previously rated as more likely to impact a participant's decision is more likely to be presented first (except for an initial introductory section).
|
Participants will review a reordered, shortened consent form.
This form is based on the shortened consent form, but the sections are reordered based on a previous study, such that sentences previously rated as more likely to impact a participant's decision is more likely to be presented first (except for an initial introductory section).
|
Experimentální: Highlighted
Participants will review a shortened consent form with a highlights box, where the highlights box includes the 10 sentences rates as most likely to impact a participant's decision from a previous study.
|
Participants will review a shortened consent form with a highlights box, where the highlights box includes the 10 sentences rates as most likely to impact a participant's decision from a previous study.
|
Experimentální: Interactive
Participants will review an interactive, shortened consent form, where hyperlinks to different sections of the consent form are provided.
The landing page includes the introductory section.
|
Participants will review an interactive, shortened consent form, where hyperlinks to different sections of the consent form are provided.
The landing page includes the introductory section.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
---|---|---|
Score for high impact questions
Časové okno: through study completion, an average of 30 minutes
|
Sum of correct answers (T/F) for any item relating to material that was rated as 50 or higher on impact on willingness to enroll in a previous study.
|
through study completion, an average of 30 minutes
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
---|---|---|
Score for low impact questions
Časové okno: through study completion, an average of 30 minutes
|
Sum of correct answers (T/F) for any item relating to material that was rated as 49 or lower on impact on willingness to enroll in a previous study.
|
through study completion, an average of 30 minutes
|
Total score for all questions
Časové okno: through study completion, an average of 30 minutes
|
Sum of correct answers (T/F) on full knowledge test.
|
through study completion, an average of 30 minutes
|
Interaction effect of format and importance on likelihood of correct answer
Časové okno: through study completion, an average of 30 minutes
|
Interaction effect in a logistic regression predicting a correct answer, based on the format of the consent form and the importance of the answer.
|
through study completion, an average of 30 minutes
|
Scores for different information categories
Časové okno: through study completion, an average of 30 minutes
|
Sum of correct answers (T/F) for each of the 20 information categories
|
through study completion, an average of 30 minutes
|
Effect of location on score
Časové okno: through study completion, an average of 30 minutes
|
Logistic regression coefficient of likelihood of predicting a correct answer, based upon the location on which the sentence appeared--uses only the shortened, and the reordered conditions.
Note that sentences appearing in the introduction (which is the first section of all treatments) must be dropped, as there will be no variation in location.
|
through study completion, an average of 30 minutes
|
Decision to enroll
Časové okno: through study completion, an average of 30 minutes
|
Likert measure of participants hypothetical decision to enroll in the study
|
through study completion, an average of 30 minutes
|
Confidence in enrollment decision
Časové okno: through study completion, an average of 30 minutes
|
Likert measure of participants confidence in hypothetical decision to enroll in the study
|
through study completion, an average of 30 minutes
|
Satisfaction with consent structure
Časové okno: through study completion, an average of 30 minutes
|
Likert measure of participants satisfaction with the consent form
|
through study completion, an average of 30 minutes
|
Perception of investigator concern for well being
Časové okno: through study completion, an average of 30 minutes
|
Likert measure of participants belief in the investigator's concerns for the participant's well-being
|
through study completion, an average of 30 minutes
|
Perception of investigator transparency
Časové okno: through study completion, an average of 30 minutes
|
Likert measure of participants belief that the investigator is trying to communicate information about the trial accurately
|
through study completion, an average of 30 minutes
|
Participant's probability estimate of the likelihood that the treatment would help control their asthma
Časové okno: through study completion, an average of 30 minutes
|
Survey question of the following form: 'If you enrolled in the trial described in the consent form, what is the probability that the treatment could help control your asthma better, where 0% means "no chance at all of helping" and 100% means "would definitely help"?' Participants provided with drop-down menu including values from 0% to 100% in increments of 1%. |
through study completion, an average of 30 minutes
|
Další výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
---|---|---|
Participant's free-response text describing what was learned from reading the informed consent document
Časové okno: through study completion, an average of 30 minutes
|
Survey question of the following form: "What are some of the key things you learned from reading the informed consent document?" Participants are then provided with an free-response text box where they are allowed to enter whatever text they want, as long as they enter some text. These responses will be coded by two independent coders, blinded to the treatment arms, using an emergent coding system to identify different topics that participants may raise. |
through study completion, an average of 30 minutes
|
Spolupracovníci a vyšetřovatelé
Sponzor
Spolupracovníci
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další identifikační čísla studie
- STUDY2017_00000268
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Popis plánu IPD
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Original consent form
-
University of FloridaEunice Kennedy Shriver National Institute of Child Health and Human Development... a další spolupracovníciDokončenoKomunikační výzkum | Postoj zdravotnického personálu | Důvěra | Postoj k počítačům | Vztahy výzkumník-subjektSpojené státy
-
Yale UniversityDokončenoVýzkum výsledků zaměřený na pacientaSpojené státy
-
University of Southern DenmarkEsbjerg Municipality; Municipality of Slagelse; Municipality of Odense; Christian... a další spolupracovníciDokončeno
-
Jules Bordet InstituteRoche Pharma AGUkončeno
-
Bio-Strath AGZentrum für Adipositas- und Stoffwechselmedizin Winterthur GmbHNeznámý
-
Baxter Healthcare CorporationDokončenoKrvácení aktivníSpojené státy, Česko, Německo, Polsko
-
Mike O'Callaghan Military HospitalDokončeno
-
Mayo ClinicDokončenoKriticky nemocnýSpojené státy
-
TakedaDokončeno
-
Mike O'Callaghan Military HospitalDokončeno